Oct 26, 2018
The US Food and Drug Administration has recently announced the fast-tracked approval of the first new pharmacological agent for the treatment of influenza to be released in more than 20 years. Baloxavir marboxil (Xofluza) was approved by the FDA for treatment of acute...
Oct 24, 2018
A list of substances that are prohibited for use by people engaged in competitive sport has been released by the World Anti-Doping Agency – effective January 2019. View the full list here
Oct 24, 2018
A high quality trial published in the New England Journal of Medicine involved random and blinded assignment of patients with acute respiratory failure or shock + hypoactive or hyperactive delirium to either receive IV haloperidol (maximum dose, 20 mg daily),...
Oct 24, 2018
An excellent piece covering a complex issue, recently published in the New England Journal of Medicine
Oct 24, 2018
The latest edition of Australia’s most authoritative text addressing modification of oral dose forms is now available for purchase from the Society of Hospital Pharmacists of Australia. For more information about the 3rd Edition of Don’t Rush to Crush,...
Oct 24, 2018
New data from the Australian Institute of Health and Welfare. One doesn’t need to be a biostatistician to see a trend here. Medications that cause osteopaenia/osteoporosis, as well as orthostasis and other factors that create a falls diathesis in the elderly...
